Paul McInulty
Consigliere Generale presso ARVINAS, INC.
Posizioni attive di Paul McInulty
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARVINAS, INC. | Consigliere Generale | 03/10/2022 | - |
Storia della carriera di Paul McInulty
Precedenti posizioni note di Paul McInulty
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELGENE | Consigliere Generale | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Formazione di Paul McInulty
| The University of Sheffield | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
Posizioni
| General Counsel | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Paul McInulty
- Esperienza
